CALLABLE KICK-IN GOAL LINKED TO WORST OF - SWISS LIFE HLDG/ABB LTD/ROCHE GS Share Price

Certificat

KOHNDU

CH1264627543

Market Closed - Swiss Exchange 08:50:01 07/05/2024 pm IST
96.9 CHF +0.52% Intraday chart for CALLABLE KICK-IN GOAL LINKED TO WORST OF - SWISS LIFE HLDG/ABB LTD/ROCHE GS
1 month+0.16%
3 months+0.31%
Date Price Change Volume
07/24/07 96.9 +0.52% 0
06/24/06 96.4 +0.16% 0

Delayed Quote Swiss Exchange

Last update May 07, 2024 at 08:50 pm IST

More quotes

Static data

Product typeReverse Convertibles
Buy / SellCALL
Underlying ROCHE HOLDING AG
Issuer UBS
KOHNDU
ISINCH1264627543
Date issued 31/05/2023
Strike 288.2 CHF
Maturity 02/06/2025 (389 Days)
Parity 0.29 : 1
Emission price 100 CHF
Emission volume N/A
Settlement both
Currency CHF

Technical Indicators

Highest since issue 100.9 CHF
Lowest since issue 94.3 CHF
Spread 10 CHF
Spread %1.02%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
222.3 CHF
Average target price
279.4 CHF
Spread / Average Target
+25.68%
Consensus
  1. Stock Market
  2. Certificates
  3. KOHNDU Certificat
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW